Carbon Monoxide to Prevent Lung Inflammation
NCT00094406 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2019-12-17
Summary
This study will examine in healthy volunteers how breathing carbon monoxide (CO) affects lung inflammation. Severe lung inflammation sometimes develops in patients with pneumonia or patients who develop serious blood stream infections. Studies in the laboratory and in animals show that CO can decrease lung inflammation.
Healthy volunteers between 18 and 40 years of age who do not smoke, are not taking any medications, do not have asthma, are not allergic to sulfa- and penicillin-based drugs, and are not pregnant may be eligible for this study. Candidates are screened with a medical history and physical examination, blood and urine tests, electrocardiogram (EKG), and chest x-ray. Subjects are enrolled in either a pilot study or the main study.
Participants undergo bronchoscopy and bronchoalveolar lavage to study the effects of endotoxin (a component of bacteria that causes inflammation similar to that in patients with lung infections) on lung function. Before the procedure, a small plastic tube (catheter) is placed in a vein to collect blood samples and another is placed in an artery to check blood pressure. For the bronchoscopy, the mouth and nasal airways are numbed with lidocaine, and a bronchoscope (thin flexible tube) is passed through the nose into the airways of the lung. A small amount of salt water is squirted through the bronchoscope into one lung and then salt water containing endotoxin is squirted into the other lung.
Following the bronchoscopy, subjects are treated with either CO or room air (placebo) for 6 hours. (Subjects in the pilot study receive treatment for only 3 hours). The gas is delivered through a cushioned mask placed over the nose and mouth. The amount of exhaled CO is measured before, during, and after inhalation of the gas. For this measurement, subjects take a deep breath to fill up their lungs and slowly exhale into a mouthpiece connected to a measuring device until they feel their lungs are empty.
After the CO treatment, a second bronchoscopy is done to examine how the lung responded to the CO or room air. This is studied in two ways. To sample the air, a large needle is used to withdraw air through the bronchoscope over about 3 seconds. Then the areas of the lung that were squirted with salt water alone and with endotoxin and salt water and are rinsed (lavage) and cells and secretions are collected.
...
Conditions
- Respiratory Distress Syndrome, Adult
Interventions
- PROCEDURE
-
Bronchoscopy
- PROCEDURE
-
Bronchoalveolar lavage
- DRUG
-
Endotoxin
- DRUG
-
Carbon Monoxide
Sponsors & Collaborators
-
National Institutes of Health Clinical Center (CC)
lead NIH
Principal Investigators
-
Anthony F Suffredini, M.D. · National Institutes of Health Clinical Center (CC)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-10-13
- Primary Completion
- 2010-03-11
- Completion
- 2010-03-11
Countries
- United States
Study Locations
More Related Trials
-
Intubated ICU Patients
NCT02171091 ·Status: TERMINATED
-
Extracorporeal Support for Respiratory Insufficiency (ECMO)
NCT00000562 ·Status: COMPLETED ·Phase: PHASE3
-
Perfluorocarbon (PFC) Inhalation Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome
NCT01391481 ·Status: UNKNOWN ·Phase: PHASE2
-
Inspiratory Effort in COVID-19
NCT04666246 ·Status: RECRUITING
-
Early Use of Noninvasive Positive Pressure Ventilation for Intro-pulmonary Acute Lung Injury
NCT01581229 ·Status: COMPLETED ·Phase: NA
-
Can a Vocal Stimulus Provoke Spontaneous Breathing in an Ischemic Stroke Patient Dependent on Mechanical Ventilation?
NCT02114996 ·Status: UNKNOWN
-
Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation
NCT00871624 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Different Inhalation Oxygen Concentrations on Postoperative Atelectasis
NCT05627024 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanical Insufflation-Exsufflation in Preventing Post Extubation Respiratory Failure in Patient With Critical Care Neuromyopathy
NCT01931228 ·Status: COMPLETED ·Phase: NA
-
Prevention of Broncho-aspiration (BA) in Adult Subjects During Their ICU Stay
NCT05284084 ·Status: COMPLETED ·Phase: NA
-
The Predictive Effect of the Inflammatory Response on the Evacuation of Mechanical Ventilation and the Mechanism
NCT02820090 ·Status: UNKNOWN
-
Retrospective Cohort Study of Low-Flow Extracorporeal Carbon Dioxide Removal (ECCO2R) System: Evaluating ECCO2R's Efficacy and Safety in Participants With Respiratory Failure
NCT07161271 ·Status: RECRUITING
-
Lung and Diaphragm-Protective Ventilation by Means of Assessing Respiratory Work
NCT03612583 ·Status: COMPLETED ·Phase: PHASE1
-
Early Non Invasive Ventilation in Immuno-compromized Patients With Acute Respiratory Failure.
NCT01915719 ·Status: COMPLETED ·Phase: NA
-
Changes in Spontaneous Ventilation in Response to Changes in Extracorporeal Carbon Dioxide Removal
NCT01953484 ·Status: UNKNOWN ·Phase: NA
-
Out-of-Hospital Non-Invasive Ventilation for Patients With Acute Respiratory Failure
NCT00885898 ·Status: COMPLETED ·Phase: NA
-
Physiological Response to Heliox21 and Air O2
NCT01498432 ·Status: UNKNOWN ·Phase: PHASE4
-
Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia
NCT04344730 ·Status: UNKNOWN ·Phase: NA
-
Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
NCT00429637 ·Status: UNKNOWN
-
Evaluation of Gas Exchange by the Measurement of Lung Diffusion for Carbon Monoxide During General Anaesthesia
NCT01503879 ·Status: UNKNOWN
-
Respiratory Supports and COVID-19 Mortality
NCT04832061 ·Status: COMPLETED
-
The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated Pneumonia
NCT01865266 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Prevalence of Rest Dyspnea and Impact of Non Invasive Ventilation on Breathing Sensations in CCHS Patients
NCT04447196 ·Status: UNKNOWN
-
Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure
NCT04408222 ·Status: COMPLETED
-
Microdosing of BAC ONE to the Distal Lung
NCT02558062 ·Status: COMPLETED ·Phase: EARLY_PHASE1